The Food and Drug Administration (FDA) has given bluebird bio the green light to resume its clinical trials of gene therapy, LentiGlobin....
LentiGlobin
It seems that the hope of gene therapy for transfusion-dependent β-thalassemia (TDT) is becoming so close. During the 62nd American Society...
